• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

116 例患者经皮室间隔缺损封堵术:不同封堵器的应用经验。

Percutaneous Closure of Ventricular Septal Defects in 116 Patients: Experience with different devices.

机构信息

Department of Child Health, Sultan Qaboos University, Muscat, Oman.

Department of Pediatric Cardiology, National Heart Center, Muscat, Oman.

出版信息

Sultan Qaboos Univ Med J. 2020 Nov;20(4):e352-e359. doi: 10.18295/squmj.2020.20.04.012. Epub 2020 Dec 21.

DOI:10.18295/squmj.2020.20.04.012
PMID:33414941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7757938/
Abstract

OBJECTIVES

This study aimed to review the experience with percutaneous closure of ventricular septal defects (VSDs) at the National Heart Center (NHC) in Muscat, Oman.

METHODS

This retrospective study was conducted from November 2008 to December 2017. Patients' electronic medical records were reviewed to identify their clinical, imaging and interventional data before and after the procedure and on the last follow-up.

RESULTS

A total of 116 patients, the majority of which were female (58%), underwent 118 percutaneous procedures for VSD closure at a median age of 3.54 years (range: 0.25-33 years) and a median weight of 12 kg (range: 3.5-78 kg). The mean diameter of the VSDs as determined by transoesophageal echocardiogram was 5.6 ± 1.9 mm (n = 105). The commonest type of VSD was perimembranous (n = 75, 63.5%). Devices were successfully placed during 111 (94.1%) procedures in 109 (94.0%) patients, with the commonest device being a Amplatzer™ duct occluder I (St. Jude Medical, Little Canada, Minnesota, USA; n = 39, 35.1%). There was no mortality. Early major cardiac complications occurred in six patients (5.5%) with device embolisation being the commonest (n = 4, 3.7%). The median follow-up period was 19 months (range: 1-84 months) in 89 (81.7%) of the patients. One patient (0.9%) required a permanent pacemaker for a complete heart block.

CONCLUSION

This study has demonstrated a good rate of VSD closure with low morbidity and no mortality using the percutaneous approach with different devices. Long-term follow-up is needed to specifically evaluate the function of adjacent structures and the long-term effects on conduction systems.

摘要

目的

本研究旨在回顾阿曼马斯喀特国家心脏中心(NHC)经皮室间隔缺损(VSD)封堵术的经验。

方法

本回顾性研究于 2008 年 11 月至 2017 年 12 月进行。回顾患者的电子病历,以确定其在手术前后及最后一次随访时的临床、影像学和介入数据。

结果

共有 116 名患者(其中大多数为女性,占 58%),在中位年龄为 3.54 岁(范围:0.25-33 岁)和中位体重为 12kg(范围:3.5-78kg)时,共进行了 118 次 VSD 封堵经皮手术。经食管超声心动图测量的 VSD 平均直径为 5.6±1.9mm(n=105)。最常见的 VSD 类型是膜周部(n=75,占 63.5%)。在 109 名(94.0%)患者中,111 次(94.1%)手术中成功放置了封堵器,最常用的封堵器是 Amplatzer™ 导管封堵器 I(圣犹达医疗用品有限公司,明尼苏达州,美国;n=39,占 35.1%)。无死亡病例。6 例(5.5%)患者发生早期重大心脏并发症,其中以器械栓塞最常见(n=4,占 3.7%)。89 名(81.7%)患者的中位随访时间为 19 个月(范围:1-84 个月)。1 名患者(0.9%)因完全性心脏传导阻滞需要植入永久性起搏器。

结论

本研究使用不同的封堵器经皮途径治疗 VSD,显示出良好的闭合率、低发病率和无死亡率。需要长期随访来具体评估毗邻结构的功能和对传导系统的长期影响。

相似文献

1
Percutaneous Closure of Ventricular Septal Defects in 116 Patients: Experience with different devices.116 例患者经皮室间隔缺损封堵术:不同封堵器的应用经验。
Sultan Qaboos Univ Med J. 2020 Nov;20(4):e352-e359. doi: 10.18295/squmj.2020.20.04.012. Epub 2020 Dec 21.
2
Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients.介入性 VSD 闭合术的短期和长期结果:儿科和成年患者的单中心经验。
Pediatr Cardiol. 2021 Jan;42(1):78-88. doi: 10.1007/s00246-020-02456-2. Epub 2020 Oct 3.
3
Effect of transcatheter closure by Amplatzer Duct Occluder II in patients with small ventricular septal defect.经导管 Amplatzer Duct Occluder II 封堵术治疗小型室间隔缺损的效果。
Cardiovasc Interv Ther. 2021 Jul;36(3):375-383. doi: 10.1007/s12928-020-00677-z. Epub 2020 May 27.
4
Percutaneous Closure of Hemodynamically Significant Postoperative Residual Ventricular Septal Defects.经皮闭合血流动力学显著的术后残余室间隔缺损
Pediatr Cardiol. 2024 Feb;45(2):272-281. doi: 10.1007/s00246-023-03366-9. Epub 2024 Jan 9.
5
Long-term outcomes of percutaneous closure of ventricular septal defects in children using different devices: A single centre experience from Egypt.经皮介入封堵术治疗儿童室间隔缺损的长期疗效: 来自埃及的单中心经验。
BMC Pediatr. 2023 Jul 31;23(1):381. doi: 10.1186/s12887-023-04194-9.
6
Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.经导管使用Amplatzer室间隔封堵器闭合先天性室间隔缺损
Am J Cardiol. 2005 Dec 19;96(12A):52L-58L. doi: 10.1016/j.amjcard.2005.09.068. Epub 2005 Nov 2.
7
Transcatheter Closure of Residual and Iatrogenic Ventricular Septal Defects: Tertiary Center Experience and Outcome.经导管闭合残余和医源性室间隔缺损:三级中心的经验和结果。
Pediatr Cardiol. 2022 Feb;43(2):308-323. doi: 10.1007/s00246-021-02722-x. Epub 2021 Sep 8.
8
The experience of transcatheter closure of postoperative ventricular septal defect after total correction.完全矫正术后经导管闭合室间隔缺损的经验
J Cardiothorac Surg. 2019 Jun 11;14(1):104. doi: 10.1186/s13019-019-0933-8.
9
Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer Vascular Plug-II.使用Amplatzer血管封堵器II经导管闭合膜周部室间隔缺损
Cardiol Young. 2016 Aug;26(6):1194-201. doi: 10.1017/S1047951115002206. Epub 2015 Oct 26.
10
Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.使用Amplatzer封堵器经皮闭合膜周部室间隔缺损——单中心经验
Kardiol Pol. 2008 Sep;66(9):941-7; discussion 948-9.

引用本文的文献

1
Safety and efficacy of using amplatzer ductal occluder type I and II for peri membranous ventricular septal defect closure: A systematic review.使用I型和II型Amplatzer导管封堵器闭合膜周部室间隔缺损的安全性和有效性:一项系统评价
ARYA Atheroscler. 2024;20(6):54-64. doi: 10.48305/arya.2024.42641.2962.
2
Experience of Percutaneous Closure of Ventricular Septal Defects in 140 Patients With Different Duct Occluders in a Tertiary Care Rural Hospital in Central India.印度中部一家三级农村医院140例采用不同封堵器经皮闭合室间隔缺损的经验
Cureus. 2023 Jul 28;15(7):e42591. doi: 10.7759/cureus.42591. eCollection 2023 Jul.

本文引用的文献

1
Percutaneous Device Closure of Congenital Isolated Ventricular Septal Defects: A Single-Center Retrospective Database Study Amongst 412 Cases.经皮器械闭合先天性孤立性室间隔缺损:412例单中心回顾性数据库研究
Pediatr Cardiol. 2020 Mar;41(3):591-598. doi: 10.1007/s00246-020-02315-0. Epub 2020 Feb 13.
2
Percutaneous Ventricular Septal Defect Closure in Patients Under 1 Year of Age.1岁以下患者的经皮室间隔缺损封堵术
Pediatr Cardiol. 2018 Jun;39(5):1009-1015. doi: 10.1007/s00246-018-1852-5. Epub 2018 Mar 15.
3
A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect.经导管装置闭合膜周部室间隔缺损的荟萃分析。
Int J Cardiol. 2018 Mar 1;254:75-83. doi: 10.1016/j.ijcard.2017.12.011. Epub 2017 Dec 7.
4
Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block?膜周部室间隔缺损介入封堵技术是否会降低心脏传导阻滞的发生率?
Cardiol Young. 2011 Jun;21(3):271-80. doi: 10.1017/S1047951110002039. Epub 2011 Feb 1.
5
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).欧洲心脏病学会成人先天性心脏病管理指南(2010年新版)
Eur Heart J. 2010 Dec;31(23):2915-57. doi: 10.1093/eurheartj/ehq249. Epub 2010 Aug 27.
6
ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease).《美国心脏病学会/美国心脏协会2008年成人先天性心脏病管理指南》:美国心脏病学会/美国心脏协会实践指南工作组(制定成人先天性心脏病管理指南的写作委员会)报告
Circulation. 2008 Dec 2;118(23):e714-833. doi: 10.1161/CIRCULATIONAHA.108.190690. Epub 2008 Nov 7.
7
Device closure of congenital ventricular septal defects.先天性室间隔缺损的器械封堵术。
Congenit Heart Dis. 2007 Mar-Apr;2(2):92-103. doi: 10.1111/j.1747-0803.2007.00080.x.
8
Transcatheter closure of perimembranous ventricular septal defects: early and long-term results.经导管闭合膜周部室间隔缺损:早期及长期结果
J Am Coll Cardiol. 2007 Sep 18;50(12):1189-95. doi: 10.1016/j.jacc.2007.03.068. Epub 2007 Sep 4.
9
Device closure of muscular ventricular septal defects in infants less than one year of age using the Amplatzer devices: feasibility and outcome.使用Amplatzer封堵器对1岁以下婴儿肌部室间隔缺损进行器械封堵:可行性及结果
Catheter Cardiovasc Interv. 2007 Jul 1;70(1):90-7. doi: 10.1002/ccd.21142.
10
Percutaneous closure of ventricular septal defects.经皮室间隔缺损封堵术
Cardiol Young. 2007 Jun;17(3):243-53. doi: 10.1017/S1047951107000431. Epub 2007 Apr 20.